Wang Yigang, Haider Husnain Khawaja, Ahmad Nauman, Ashraf Muhammad
Department of Pathology and Laboratory Medicine, University of Cincinnati Medical Center, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267-0529, USA.
Vascul Pharmacol. 2005 Apr-May;42(5-6):253-64. doi: 10.1016/j.vph.2005.02.008. Epub 2005 Mar 21.
Mitochondria are being increasingly studied for their critical role in cell survival. Multiple diverse signaling pathways have been shown to converge on the K+-sensitive ATP channels as the effectors of cytoprotection against necrosis and apoptosis. The role of potassium channel openers in regulation and transformation of cell membrane excitability, action potential and electrolyte transfer has been extensively studied. Cardiac mitoK(ATP) channels are the key effectors in cardioprotection during ischemic preconditioning, as yet with an undefined mechanism. They have been hypothesized to couple myocardial metabolism with membrane electrical activity and provide an excellent target for drug therapy. A number of K(ATP) channel openers have been characterized for their beneficial effects on the myocardium against ischemic injury. This review updates recent progress in understanding the physiological role of K(ATP) channels in cardiac protection induced by preconditioning and highlights relevant questions and controversies in the light of published data.
线粒体因其在细胞存活中的关键作用而受到越来越多的研究。多种不同的信号通路已被证明汇聚于钾离子敏感性ATP通道,作为针对坏死和凋亡的细胞保护效应器。钾通道开放剂在调节和转变细胞膜兴奋性、动作电位及电解质转运方面的作用已得到广泛研究。心脏线粒体ATP敏感性钾通道是缺血预处理期间心脏保护的关键效应器,但其机制尚不清楚。它们被推测可将心肌代谢与膜电活动相耦合,并为药物治疗提供了一个绝佳靶点。一些ATP敏感性钾通道开放剂已被证实对心肌抵抗缺血性损伤具有有益作用。本综述更新了对ATP敏感性钾通道在预处理诱导的心脏保护中的生理作用的理解方面的最新进展,并根据已发表的数据突出了相关问题和争议。